Loading...
Loading...
Pro Medicus Ltd./ADR
Pro Medicus Ltd./ADR. Spoken Alpha tracks PMCUF's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks PMCUF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 80% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PMCUF.
curl https://api.spokenalpha.com/v1/companies/PMCUF| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.68 | $3.01 | +22.2% | -1.5% | +0.2% |
| Q4 FY2026 | $3.67 | $2.78 | +32.1% | +6.9% | +5.1% |
| Q3 FY2026 | $3.34 | $2.86 | +16.8% | +5.8% | +4.4% |
| Q2 FY2026 | $3.53 | $2.89 | +22.3% | +8.5% | +8.6% |
| Q1 FY2025 | $3.71 | $3.09 | +20.0% | +7.9% | +5.5% |
| Q4 FY2025 | $3.78 | $2.90 | +30.3% | -2.3% | -0.8% |
| Q3 FY2025 | $3.63 | $2.87 | +26.5% | +6.1% | +3.4% |
| Q2 FY2025 | $3.81 | $3.04 | +25.2% | +0.6% | +2.7% |
| Q1 FY2024 | $3.67 | $3.08 | +19.3% | +4.0% | +4.8% |
| Q4 FY2024 | $3.60 | $3.00 | +20.0% | +9.1% | +7.1% |